Vascular Biogenics (VBLT) P/E Ratio
P/E Ratio as of Jul 25, 2025: -0.03
Average-0.0300
Median-0.0300
Minimum-0.0300
Maximum-0.0300
-0.03
Past Month0.00 (0.00%)
The P/E ratio for Vascular Biogenics (VBLT) is -0.03 as of Jul 25, 2025. This represents a decrease of -25.00% compared to its 12-month average P/E ratio of -0.04. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Vascular Biogenics P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Vascular Biogenics’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Vascular Biogenics to industry peers.
Vascular Biogenics P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Vascular Biogenics’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Vascular Biogenics to industry peers.
Vascular Biogenics (VBLT) P/E Ratio Insights
See Vascular Biogenics’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in Vascular Biogenics (VBLT)
Order type
Buy in
Order amount
Est. shares
0 shares
Vascular Biogenics (VBLT) P/E Ratio Historic Data
| Date | Stock price | P/E ratio |
|---|---|---|
| Jul 1, 2025 | — | -0.03 |
| Jun 2, 2025 | — | -0.03 |
| May 1, 2025 | — | -0.03 |
| Apr 1, 2025 | — | -0.03 |
| Mar 3, 2025 | — | -0.03 |
| Feb 3, 2025 | — | -0.03 |
| Jan 2, 2025 | — | -0.03 |
Vascular Biogenics (VBLT) End of Year P/E Ratio
| Date | P/E ratio | Change |
|---|---|---|
| 2025 | -0.03 | 0.00% |
| 2024 | -0.03 | -88.46% |
| 2023 | -0.26 | +8.33% |
| 2022 | -0.24 | -94.35% |
| 2021 | -4.25 | +27.25% |
| 2020 | -3.34 | — |
FAQs About Vascular Biogenics (VBLT) P/E ratio
The latest P/E ratio of Vascular Biogenics (VBLT) is -0.03, as of Jul 25, 2025. This is calculated based on its current stock price and earnings per share (EPS).
Vascular Biogenics’s last 12-month average P/E ratio is -0.04, compared to its current P/E ratio of -0.03. This reflects a decrease of -25.00%.
Vascular Biogenics’s current P/E ratio of -0.03 is lower than its last 12-month average P/E of -0.04. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Vascular Biogenics’s average P/E ratio over the last 3 years is -0.33. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Vascular Biogenics’s average P/E ratio over the last 5 years is -1.56. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.